GSK’s fair value estimate has seen a modest increase, rising from $16.63 to $17.36 per share. The discount rate remains ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced the purchase of 320,000 of its own ordinary shares as part of its ...

GSK plc has announced the repurchase of 180,000 ordinary shares as part of its ongoing buyback program, executed through BNP Paribas SA. The shares, purchased at prices ranging from 1,669.50p to 1,761 ...

The FTSE 100 opened higher on Wednesday, lifted by strength in miners, upbeat corporate results from GSK and Next, and rising ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

British pharmaceutical group GSK on Wednesday raised its full-year outlook after strong sales growth in its third quarter, ...

GSK and Smith & Nephew outperformed forecast-beating Barclays today as the FTSE 100 index stayed within reach of a 13th consecutive improvement. London’s top flight stood 5.10 points lower at 8458.36, ...

OPEN The FTSE 100 was expected to open 6.1 points higher ahead of the bell on Friday after wrapping up the previous session 0.67% stronger at 9,578.57.

LONDON (Reuters Breakingviews) - GlaxoSmithKline is making a play for the premium aisle of consumer health. The maker of Lemsip drinks and Advil painkillers rejected Unilever’s 50 billion pound offer ...

Over in the US, the rally across AI names has sent the S&P 500 and Nasdaq 100 to fresh record highs, as well as the SOX ...

GlaxoSmithKline had big growth plans for 2020 across its brands—and then the COVID-19 pandemic hit. So the company scrambled to rethink and prioritize “ruthlessly” to find a new way forward. That ...